Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Mohs Micrographic Surgery for Superficially Invasive Squamous Cell Carcinoma

Rationale for Mohs Surgery in Superficially Invasive SCC

  • The National Comprehensive Cancer Network recommends Mohs micrographic surgery (MMS) for superficially invasive squamous cell carcinoma due to its superior cure rates and tissue conservation, particularly for high-risk tumors and those in anatomically sensitive locations 1, 2
  • MMS provides complete assessment of all peripheral and deep margins, which is critical for ensuring complete tumor removal and minimizing recurrence risk, as documented by the National Comprehensive Cancer Network and the British Journal of Dermatology 1, 3
  • MMS has superior efficacy compared to other treatment modalities, with 5-year recurrence rates of only 3.1% for primary SCC compared to 8.1% for standard excision, according to the American Academy of Dermatology 2

Indications for Mohs in Superficially Invasive SCC

  • The National Comprehensive Cancer Network and the American Academy of Dermatology indicate that MMS is particularly suitable for superficially invasive SCC in high-risk anatomic locations, such as the H-zone of the face, periorbital, perioral, and ears 1, 2
  • Tumors with poorly defined clinical margins are also an indication for MMS, as recommended by the British Journal of Dermatology 3, 4
  • Recurrent tumors can benefit from MMS, which shows a 10% recurrence rate compared to 23.3% with standard excision, according to the American Academy of Dermatology 2

Alternative Treatment Options

  • The National Comprehensive Cancer Network suggests that standard excision with complete circumferential peripheral and deep margin assessment (CCPDMA) using intraoperative frozen section assessment can be an alternative to MMS when it is unavailable or inappropriate 1, 5
  • For low-risk, small (<1 cm), well-differentiated tumors on sun-exposed sites, curettage and electrodesiccation may be considered, as recommended by the British Journal of Dermatology 3, 6
  • Radiation therapy can be considered for non-surgical candidates, typically reserved for patients older than 60 years due to long-term sequelae concerns, according to the National Comprehensive Cancer Network 1, 5

Important Considerations and Caveats

  • The American Academy of Dermatology recommends that the tumor debulk specimen from MMS should be submitted for paraffin sections to document high-risk features when needed 2
  • Incomplete surgical excision is associated with worse prognosis; when using standard excision, consider delaying wound repair until negative margins are confirmed, as advised by the British Journal of Dermatology 3, 4